BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7607965)

  • 1. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.
    Matsumoto K; Takahashi S; Sato A; Imaizumi M; Higano S; Sakamoto K; Asakawa H; Tada K
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):913-8. PubMed ID: 7607965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
    Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK
    Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer.
    Butler RW; Hill JM; Steinherz PG; Meyers PA; Finlay JL
    J Clin Oncol; 1994 Dec; 12(12):2621-9. PubMed ID: 7989937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis.
    Chan YL; Roebuck DJ; Yuen MP; Yeung KW; Lau KY; Li CK; Chik KW
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):759-63. PubMed ID: 11395245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
    Waber DP; Tarbell NJ; Fairclough D; Atmore K; Castro R; Isquith P; Lussier F; Romero I; Carpenter PJ; Schiller M
    J Clin Oncol; 1995 Oct; 13(10):2490-6. PubMed ID: 7595698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
    Ficek K; Blamek S; Syguła D; Miszczyk L; Sońta-Jakimczyk D; Tarnawski R
    Acta Neurochir Suppl; 2010; 106():195-7. PubMed ID: 19812948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.
    Rosso P; Terracini B; Fears TR; Jankovic M; Fossati Bellani F; Arrighini A; Carli M; Cordero di Montezemolo L; Garrè ML; Guazzelli C
    Int J Cancer; 1994 Nov; 59(4):451-6. PubMed ID: 7960210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.
    Waber DP; Tarbell NJ; Kahn CM; Gelber RD; Sallan SE
    J Clin Oncol; 1992 May; 10(5):810-7. PubMed ID: 1569453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.
    Pande AR; Ando K; Ishikura R; Nagami Y; Ogawa M; Kamikonya N; Kaneda Y; Tanizawa T; Nakao N
    Radiat Med; 2006 Aug; 24(7):515-9. PubMed ID: 17058146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
    Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
    Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate.
    Liu HC; Liang DC; Chen SH; Lo CY; Tseng KP; Kuo TB; Chen HJ; Wang SJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):107-10. PubMed ID: 8935408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cranial computed tomography in children with acute lymphoblastic leukemia after prophylactic treatment with cranial radiation therapy and intrathecal methotrexate.
    Liang DC; Lin JC; Shih SL; Huang JK; Wong LY; Shu SG; Hsieh YL; Yang CP; Tsai YM; Lin ST
    Cancer; 1993 Mar; 71(6):2105-8. PubMed ID: 8443759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
    Conter V; Schrappe M; Aricó M; Reiter A; Rizzari C; Dördelmann M; Valsecchi MG; Zimmermann M; Ludwig WD; Basso G; Masera G; Riehm H
    J Clin Oncol; 1997 Aug; 15(8):2786-91. PubMed ID: 9256120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.